Hardelid, P <br/><br/>
Prescribing of neuraminidase inhibitors for influenza in UK primary care since the 2009 pandemic.  [electronic resource] 

 -  Epidemiology and infection  Mar 2016 
 - 772-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1469-4409 
<br/><br/><label>Standard No.: </label>10.1017/S095026881500206X  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--administration & dosage<br/>Binomial Distribution<br/>Child<br/>Child, Preschool<br/>Drug Prescriptions--statistics & numerical data<br/>Female<br/>Humans<br/>Infant<br/>Influenza, Human--drug therapy<br/>Male<br/>Middle Aged<br/>Neuraminidase--antagonists & inhibitors<br/>Primary Health Care--statistics & numerical data<br/>Regression Analysis<br/>Seasons<br/>United Kingdom<br/>Young Adult